Crossmark

HR23B pathology preferentially co-localizes with p62, pTDP-43 and poly-GA in C9ORF72-linked frontotemporal dementia and amyotrophic lateral sclerosis

Crossref DOI link: https://doi.org/10.1186/s40478-019-0694-6

Published Online: 2019-03-13

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Riemslagh, Frederike W. https://orcid.org/0000-0002-8530-3339
Lans, Hannes

Seelaar, Harro

Severijnen, Lies-Anne W. F. M.

Melhem, Shamiram

Vermeulen, Wim

Aronica, Eleonora

Pasterkamp, R. Jeroen

van Swieten, John C.

Willemsen, Rob
Funding

Funding for this research was provided by:

ALS stichting (2014-28)

EU Joint Programme – Neurodegenerative Disease Research (733051042, 733051042)

European Research Council (340988)
License Information

Text and Data Mining valid from 2019-03-13
More Information

Article History

Received: 31 January 2019

Accepted: 5 March 2019

First Online: 13 March 2019

Ethics approval and consent to participate

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All participants gave written informed consent for all obtained materials. The study was approved by the Medical and Ethical Review Committee of the Erasmus Medical Center.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.